UC101 is the world’s first FDA IND-approved umbilical cord blood-derived allogeneic CAR-T therapy. T cells derived from umbilical cord blood possess the natural advantages of low immunogenicity and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback